{"nct_id":"NCT01335399","title":"Phase III Study of Lenalidomide and Dexamethasone With or Without Elotuzumab to Treat Newly Diagnosed, Previously Untreated Multiple Myeloma","status":"COMPLETED","status_verified_date":"2022-09","start_date":"2011-08-04","start_date_type":"ACTUAL","primary_completion_date":"2019-10-01","primary_completion_date_type":"ACTUAL","completion_date":"2021-09-03","completion_date_type":"ACTUAL","phases":["PHASE3"],"tickers":["BMY"]}